Quick Answer
Onconetix, Inc. reported Stockholders Equity of $8.54 million for the year ending 2024.
- Onconetix, Inc. showed an increase of +252.5% in Stockholders Equity from 2023 to 2024.
- This data is from Onconetix, Inc.'s annual report (Form 10-K), filed with the SEC on June 2, 2025.
- XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2021: $4.45 million | Q2 2021: $3.69 million | Q3 2021: $2.63 million | Q4 2021: $1.45 million | Q1 2022: $16.53 million | Q2 2022: $20.57 million | Q3 2022: $25.73 million | Q1 2023: $19.69 million | Q2 2023: $13.08 million | Q3 2023: $10.24 million | Q1 2024: -$21.53 million | Q2 2024: -$35.81 million | Q3 2024: $33.91 million.
- Over the full 5 years of available data (2020 to 2024), Onconetix, Inc.'s Stockholders Equity has grown by 80.5%.
- Historical annual values: Fiscal year 2024: $8.54 million | Fiscal year 2023: -$5.60 million | Fiscal year 2022: $22.39 million | Fiscal year 2021: $1.45 million | Fiscal year 2020: $4.73 million.
- Data sourced from SEC EDGAR public filings as of August 7, 2026.
Last verified: